Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer.
Raghavan
D
D
Urological Cancer Research Unit, Royal Prince Alfred Hospital, Camperdown, N.S.W., Australia.
Grundy
R
R
Lancaster
L
L
D001294:Attitude to Health; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000523:psychology; D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000523:psychology
D002945:Cisplatin